Patient-centered

以患者为中心
  • 文章类型: Journal Article
    经导管主动脉瓣置换术(TAVR)是严重症状性主动脉瓣狭窄患者的重要治疗选择。确定优秀结果的预测因素很重要(良好的临床结果,在TAVR之后花费更多的时间),这些时间可能会有所改善。
    本研究的目的是使用机器学习来确定TAVR后临床相关的以患者为中心的结果的潜在可修改的预测因子。
    我们使用来自21家医院的8,332例TAVR病例(2016年1月至2021年12月)的数据来训练具有57例患者特征的随机森林模型(人口统计,合并症,手术风险评分,实验室值,健康状况评分)和护理过程参数来预测终点,一个复合参数,指定一个极好的结果,包括没有重大并发症(住院或30天),TAVR后的停留时间为1天或更短,出院回家,没有重新接纳,还活着30天.我们使用具有交叉验证的递归特征消除和Shapley加法解释特征重要性来识别具有最高预测值的参数。
    最终的随机森林模型保留了29个预测因子(15个患者特征和14个护理过程组件);曲线下的面积,灵敏度,特异性分别为0.77、0.67和0.73。确定了具有相对较高的Shapley加法解释值的四个潜在可修改的预测因子:麻醉类型,直接移动到TAVR后的降压单元,导管插入和TAVR之间的时间,和程序前的停留时间。
    这项研究确定了TAVR后优异结局的四个潜在可修改的预测因子,这表明机器学习与医院层面的数据相结合可以为可修改的护理组件提供信息,这可以为接受TAVR的患者提供更好的护理。
    UNASSIGNED: Transcatheter aortic valve replacement (TAVR) is an important treatment option for patients with severe symptomatic aortic stenosis. It is important to identify predictors of excellent outcomes (good clinical outcomes, more time spent at home) after TAVR that are potentially amenable to improvement.
    UNASSIGNED: The purpose of the study was to use machine learning to identify potentially modifiable predictors of clinically relevant patient-centered outcomes after TAVR.
    UNASSIGNED: We used data from 8,332 TAVR cases (January 2016-December 2021) from 21 hospitals to train random forest models with 57 patient characteristics (demographics, comorbidities, surgical risk score, lab values, health status scores) and care process parameters to predict the end point, a composite of parameters that designated an excellent outcome and included no major complications (in-hospital or at 30 days), post-TAVR length of stay of 1 day or less, discharge to home, no readmission, and alive at 30 days. We used recursive feature elimination with cross-validation and Shapley Additive Explanation feature importance to identify parameters with the highest predictive values.
    UNASSIGNED: The final random forest model retained 29 predictors (15 patient characteristics and 14 care process components); the area under the curve, sensitivity, and specificity were 0.77, 0.67, and 0.73, respectively. Four potentially modifiable predictors with relatively high Shapley Additive Explanation values were identified: type of anesthesia, direct movement to stepdown unit post-TAVR, time between catheterization and TAVR, and preprocedural length of stay.
    UNASSIGNED: This study identified four potentially modifiable predictors of excellent outcome after TAVR, suggesting that machine learning combined with hospital-level data can inform modifiable components of care, which could support better delivery of care for patients undergoing TAVR.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:卓越诊断是指获得对患者病情的准确和精确解释的最佳过程,并结合患者及其护理伙伴的观点。患者报告措施(PRM),旨在捕获患者报告的信息,有潜力为实现卓越诊断做出贡献。我们旨在制定一套路线图,说明目标并指导PRM的开发以实现卓越诊断(“路线图”)。
    方法:我们使用了来自环境文献扫描的迭代输入,专家咨询,和病人的声音和采用以人为本的设计(HCD)和注重公平的路线图。这些方法的最终活动是专家召集。
    结果:使用PRM可以实现卓越诊断的多个目标,包括但不限于:(1)用于诊断连续性的PRM,(2)诊断PRM警报,(3)基于PRM的质量改进,(4)用于研究的PRM,(5)用于常规筛选的PRM,(6)基于PRM的诊断卓越人群水平模式,和(7)支持患者讲故事的PRM。公平被视为一个贯穿各领域的目标。总之,这些目标和未来的目标支持实现患者报告的卓越诊断愿景。路线图是作为动态工具开发的,用于说明PRM与特定步骤相关的反馈循环以实现目标,预期时间框架(8-15年),协同作用,以促进,和需要克服的挑战。路线图在开发阶段的后续PRM中是实用的,背书,实施和缩放,并根据这些措施采取行动。时间框架估计假设在这些阶段之间立即过渡,并且没有通过激励和积极协调来加速。
    结论:用于卓越诊断的PRM具有连接患者观点的潜力,股本,和可实现的目标。路线图提供了一种设计方法,可以在不同的利益相关者之间协调测量活动。路线图还强调了收集和使用患者报告信息的方式的多功能性,从临床环境到公共卫生环境。患者报告的卓越诊断不能仅仅作为自上而下的努力来建立,但本质上受益于自下而上的方法。
    BACKGROUND: Diagnostic excellence refers to the optimal process to attain an accurate and precise explanation about a patient\'s condition and incorporates the perspectives of patients and their care partners. Patient-reported measures (PRMs), designed to capture patient-reported information, have potential to contribute to achieving diagnostic excellence. We aimed to craft a set of roadmaps illustrating goals and guiding the development of PRMs for diagnostic excellence (\"Roadmaps\").
    METHODS: We used iterative inputs from environmental literature scans, expert consultations, and patient voice and employed human-centred design (HCD) and equity-focused road-mapping. The culminating activity of these approaches was an Expert Convening.
    RESULTS: Use of PRMs can achieve multiple goals for diagnostic excellence, including but not limited to: (1) PRMs for diagnostic continuity, (2) diagnostic PRM alerts, (3) PRM-based quality improvement, (4) PRMs for research, (5) PRMs for routine screening, (6) PRM-based diagnostic excellence population-level patterns, and (7) PRMs supporting patient storytelling. Equity is considered as a cross-cutting goal. Altogether these and future goals support operationalising a vision of patient-reported diagnostic excellence. Roadmaps were developed as a dynamic tool to illustrate PRMs in relation to specific steps with feedback loops to accomplish goals, anticipated timeframes (8-15 years), synergies to foster, and challenges to overcome. Roadmaps are practical in their following PRMs through the stages of development, endorsement, implementation and scaling, and acting upon those measures. Timeframe estimates assume immediate transitions between these stages and no acceleration through incentives and active coordination.
    CONCLUSIONS: PRMs for diagnostic excellence have potential to connect patient perspectives, equity, and achievable goals. Roadmaps offer a design approach to enable coordinating measurement activities among diverse stakeholders. Roadmaps also highlight versatility in ways patient-reported information can be collected and used, from clinical settings to public health contexts. Patient-reported diagnostic excellence cannot be established as a solely top-down endeavour, but inherently benefits from bottom-up approaches.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    慢性肾脏病(CKD)在全球范围内代表着重大的健康挑战,特别是在接受慢性血液透析的患者中。精心的营养和药物处方在有效管理这些患者以优化血清电解质方面起着关键作用,如钾,磷,和蛋白质的摄入。此外,由于饮食限制和严格的用药时间表,这些患者可能会遭受心理困扰。本研究探讨了以人为中心的IARA模型在改善接受血液透析治疗的CKD患者的生理指标和生活质量方面的有效性。为了证明IARA模型的有效性,纳入60例接受每周三次血液透析的患者(M=40;F=20;60.5±9.9岁),并随机和盲目地分配到对照组或IARA组。异常血钾的减少,磷,并调查了总蛋白质水平,通过SF-12问卷进行心理状态。初步发现显示,与对照组相比,IARA组异常血液K(>5.0mmol/L)和P(>4.5mmol/L)水平的频率明显减少。特别是,K降低约40%(OR=0.57;95%CL=0.23/1.46),P降低约15%(OR=0.86;95%CL=0.27/2.74).在每次血液透析期间,患者的液体摄入量也观察到类似的趋势。IARA组中高危患者的频率比对照组低50%(OR=0.50;95%CL=0.07/3.79)。尽管这项研究的初步结果表明,IARA模型可能对CKD患者的主观幸福感和生活质量(QoL)产生积极影响,需要进一步的研究来了解IARA干预的长期影响.
    Chronic kidney disease (CKD) globally represents a significant health challenge, particularly among patients undergoing chronic hemodialysis. A careful nutritional and pharmacological prescription plays a key role in the effective management of these patients to optimize serum electrolytes, such as potassium, phosphorus, and protein intake. Furthermore, these patients can suffer psychological distress due to dietary restrictions and tight medication schedules. The present study explores the effectiveness of the person-centered IARA model in improving physiological markers and quality of life in CKD patients undergoing hemodialysis treatment. To demonstrate the effectiveness of the IARA model, 60 patients (M = 40; F = 20; 60.5 ± 9.9 years) undergoing thrice-weekly hemodialysis sessions were enrolled and randomly and blindly assigned to the Control or IARA group. The reduction in abnormal blood potassium, phosphorus, and total protein levels was investigated, alongside the psychological state through the SF-12 questionnaire. Preliminary findings showed a discernible reduction in the frequency of abnormal blood K (> 5.0 mmol/L) and P (> 4.5 mmol/L) levels in the IARA group compared to the Control group. In particular, such reductions were approximately 40% for K (OR = 0.57; 95% CL = 0.23/1.46) and about 15% for P (OR = 0.86; 95% CL = 0.27/2.74). A similar tendency was also observed for patient fluid intake during each hemodialysis session, with the frequency of higher-risk patients in the IARA group being 50% lower (OR = 0.50; 95% CL = 0.07/3.79) than that of the Control group. Although preliminary findings from this study suggest that the IARA model may have a positive effect on CKD patients\' subjective wellbeing and quality of life (QoL), further research is needed to understand the long-term impact of the IARA intervention.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    牙周治疗后的患者依从性对于预测疾病的预后和维持治疗结果极为重要。因此,本研究旨在探讨牙周炎患者对治疗结果的认知。通过预先验证的问卷,在单个牙科中心的牙周炎患者中进行了横断面研究,该问卷通过使用便利的抽样技术分发给牙周诊所等候区的每个参与者。除频率和百分比外,还使用了中位数和四分位数范围。使用Mann-WhitneyU和Kruskal-Wallis检验进行双变量分析。在300名男性和女性参与者中,当前疼痛水平的中位数得分(四分位数范围)表明男性比女性经历更多的疼痛,男性的中位数为5分(0-7分),女性为4分(0-6分)。然而,男女期望和预期疼痛水平的中位数(四分位数范围)为0(0-1),0(0-4)。预期的男性和女性之间的中位数得分等级存在显着差异,苦恼,成功,和重要性水平(p值<0.05)。牙周炎患者为接受牙周病治疗的个人提供了宝贵的见解,表明患者对预期的牙周结局水平的总体满意度。
    Patient compliance following periodontal therapy is extremely important in predicting the prognosis of the disease and maintaining treatment outcomes. Therefore, this study aimed to investigate the perception of periodontitis patients about treatment outcomes. A cross-sectional study was conducted among periodontitis patients in a single dental center through a pre-validated questionnaire that was distributed to each participant in the waiting area of periodontal clinics by utilizing a convenience sampling technique. Median and interquartile ranges were used in addition to frequency and percentages. Bivariate analyses were performed using the Mann-Whitney U and Kruskal-Wallis test. Among the 300 male and female participants, the median score (interquartile range) of the current level of pain revealed that males experienced more pain than females, with a median score of 5 (0-7) for males and 4 (0-6) for women. However, the median (interquartile range) for desired and expected pain levels in both genders was 0 (0-1), 0 (0-4). There were significant differences in median score ratings between males and females for expected, distress, success, and importance levels (p-value < 0.05). Patients with periodontitis provided valuable insights into the experiences of individuals undergoing treatment for periodontal disease, indicating overall patient satisfaction with the expected levels of periodontal outcomes.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:母乳喂养对于分娩者及其婴儿的最佳健康至关重要。Shared,以患者为中心的目标,医疗保健团队成员,社区团体,家庭可以帮助促进母乳喂养的成功是必要的,从患者的角度来看,定义和衡量母乳喂养成功的方法也是如此。方法:母乳喂养医学学会和我们的姐妹们到处合作,采用多方法方法来确定对父母最重要的母乳喂养优先事项。结果:我们确定了(1)父母和家庭定义的成功母乳喂养旅程的关键组成部分,(2)研究优先事项,使家庭能够实现母乳喂养。结论:传播这些发现可以促进与出生父母和家庭共同设计的研究工作,并反映他们的优先事项。
    Background: Breastfeeding is critically important for optimal health of both birthing people and their infants. Shared, patient-centered goals of how health care team members, community groups, and families can help facilitate breastfeeding success are needed, as are ways to define and measure what breastfeeding success looks like from the patient\'s perspective. Methods: The Academy of Breastfeeding Medicine and Reaching Our Sisters Everywhere\'s collaborated in a multi-methods approach to identify breastfeeding priorities most important to parents. Results: We identified (1) Key components of a successful breastfeeding journey defined by parents and families, (2) Research priorities that will enable families to achieve breastfeeding. Conclusion: Dissemination of these findings can foster research efforts that are codesigned with birthing parents and families and reflect their priorities.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:为患有多种慢性疾病(MCC)的老年人提供医疗保健具有挑战性。多药和复杂的治疗计划可能导致高治疗负担和不良事件的风险。对于临床医生来说,管理MCC患者的复杂性几乎没有空间来确定什么是重要的,并使护理方案与患者的健康优先事项保持一致。需要新的护理方法来应对这些挑战。在这个临床试验中,我们评估创新的实施和有效性结果,结构化,以患者为中心的护理方法(PatientPrioritiesCare;PPC),用于减轻治疗负担,并使医疗保健决策与MCC老年人的健康优先事项保持一致。
    方法:这是一个多站点,评估员-盲,双臂,平行杂交1型随机对照试验。我们正在招募396名年龄较大(65岁以上)的MCC退伍军人,他们在退伍军人事务医疗中心接受初级保健。退伍军人被随机分配到PPC或常规护理。在PPC臂中,退伍军人可以与研究促进者进行简短的电话通话,以确定他们的个人健康优先事项。然后,初级保健提供者使用这些信息在他们确定的诊所预约期间使医疗保健与退伍军人的优先事项保持一致.在基线和4个月随访时收集数据,以评估治疗负担的变化以及家庭和社区服务的使用。还收集了形成性和总结性评估,以根据Proctor的实施框架评估实施结果。
    结论:这项工作有可能通过个性化医疗保健和帮助患者实现对他们最重要的目标来显着提高护理标准。
    BACKGROUND: Providing healthcare for older adults with multiple chronic conditions (MCC) is challenging. Polypharmacy and complex treatment plans can lead to high treatment burden and risk for adverse events. For clinicians, managing the complexities of patients with MCC leaves little room to identify what matters and align care options with patients\' health priorities. New care approaches are needed to navigate these challenges. In this clinical trial, we evaluate implementation and effectiveness outcomes of an innovative, structured, patient-centered care approach (Patient Priorities Care; PPC) for reducing treatment burden and aligning health care decisions with the health priorities of older adults with MCC.
    METHODS: This is a multisite, assessor-blind, two-arm, parallel hybrid type 1 randomized controlled trial. We are enrolling 396 older (65+) Veterans with MCC who receive primary care at the Veterans Affairs Medical Center. Veterans are randomly assigned to either PPC or usual care. In the PPC arm, Veterans have a brief telephone call with a study facilitator to identify their personal health priorities. Then, primary care providers use this information to align healthcare with Veteran priorities during their established clinic appointments. Data are collected at baseline and 4-month follow up to assess for changes in treatment burden and use of home and community services. Formative and summative evaluations are also collected to assess for implementation outcomes according to Proctor\'s implementation framework.
    CONCLUSIONS: This work has the potential to significantly improve the standard of care by personalizing healthcare and helping patients achieve what is most important to them.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:人口老龄化是医疗保健系统的挑战,必须确定满足其需求的策略。实践以患者为中心的护理已被证明对该患者群体有益。以患者为中心的护理的效果称为以患者为中心的结果,可以使用结果测量来评估。
    目的:主要目的是回顾和绘制与老年人以患者为中心的结果和以患者为中心的结果测量相关的现有知识,以及确定关键概念和知识差距。研究问题是:如何衡量老年人以患者为中心的结果,哪些以患者为中心的结果对老年人最重要?
    方法:范围综述。
    方法:搜索电子数据库中的相关出版物,2000年至2021年的灰色文献数据库和网站。两名审稿人独立筛选标题和摘要,接下来是全文回顾和使用数据提取框架提取数据。
    结果:纳入了18项研究,其中6名患者和/或专家参与了确定结果的过程。对老年人来说最重要的结果被解释为:获得护理和体验,自治和控制,认知,日常生活,情绪健康,falls,一般健康,药物,总生存率,疼痛,参与决策,物理功能,身体健康,死亡的地方,社会角色功能,症状负担,和在医院度过的时间。最常提及/使用的结果测量工具是成人社会护理结果工具包(ASCOT),EQ-5D,步态速度,Katz-ADL指数,患者健康问卷(PHQ9),SF/RAND-36和4项筛选Zarit负担访谈。
    结论:很少有研究调查老年人对他们最重要的事情的看法,这形成了该领域的知识鸿沟。未来的研究应该集中在为老年人提供他们认为对他们最重要的声音。
    BACKGROUND: The aging population is a challenge for the healthcare system that must identify strategies that meet their needs. Practicing patient-centered care has been shown beneficial for this patient-group. The effect of patient-centered care is called patient-centered outcomes and can be appraised using outcomes measurements.
    OBJECTIVE: The main aim was to review and map existing knowledge related to patient-centered outcomes and patient-centered outcomes measurements for older people, as well as identify key-concepts and knowledge-gaps. The research questions were: How can patient-centered outcomes for older people be measured, and which patient-centered outcomes matters the most for the older people?
    METHODS: Scoping review.
    METHODS: Search for relevant publications in electronical databases, grey literature databases and websites from year 2000 to 2021. Two reviewers independently screened titles and abstracts, followed by full text review and extraction of data using a data extraction framework.
    RESULTS: Eighteen studies were included, of which six with involvement of patients and/or experts in the process on determine the outcomes. Outcomes that matter the most to older people was interpreted as: access to- and experience of care, autonomy and control, cognition, daily living, emotional health, falls, general health, medications, overall survival, pain, participation in decision making, physical function, physical health, place of death, social role function, symptom burden, and time spent in hospital. The most frequently mentioned/used outcomes measurements tools were the Adult Social Care Outcomes Toolkit (ASCOT), EQ-5D, Gait Speed, Katz- ADL index, Patient Health Questionnaire (PHQ9), SF/RAND-36 and 4-Item Screening Zarit Burden Interview.
    CONCLUSIONS: Few studies have investigated the older people\'s opinion of what matters the most to them, which forms a knowledge-gap in the field. Future research should focus on providing older people a stronger voice in what they think matters the most to them.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目标:作为一项更大的混合方法研究的一部分,以更好地定义佐治亚州获得SRH护理的公平性,本分析旨在了解:1)个人如何为其SRH服务定义优质护理;2)在寻求SRH护理时,护理质量如何显著.
    方法:从2019年1月到2020年2月,我们对佐治亚州郊区有怀孕能力的人进行了生活史访谈。我们使用主题分析法对访谈进行了分析。
    结果:SRH护理质量是由健康中心环境的经验决定的,与供应商,和工作人员。研究参与者强调了与可信的SRH护理相关的因素,如表现出同情心,尊重和不评判,花时间,提供信息,和保证机构。参与者还表达了对解决个人生活经历的整体护理的愿望。参与者在寻求护理时考虑了护理质量,但有时不得不权衡对质量的偏好与负担能力问题。
    结论:获得以人为中心的优质护理是实现获得SRH服务的重要组成部分。公平获取和质量的措施应考虑到优质护理的经验,其中包括提供者和员工的互动以及更大的医疗保健环境和使用优质护理的能力,尽管存在财务限制。
    结论:优质的计划生育护理应包括临床医生和工作人员,以表现出同情心,提供尊重和非评判性的护理,花时间和病人在一起,提供信息,确保机构在决策中,以及解决个人的生活经验。
    OBJECTIVE: As part of a larger mixed-methods study to better define equity in access to sexual and reproductive health (SRH) care in Georgia, this analysis sought to understand: (1) how individuals define quality care for their SRH services; and (2) how quality of care is salient in their SRH care-seeking.
    METHODS: From January 2019 to February 2020, we conducted life history interviews with individuals with the capacity to become pregnant in suburban areas in Georgia. We analyzed interviews using thematic analysis.
    RESULTS: SRH care quality was shaped by experiences with health center environment, with providers, and with staff. Study participants emphasized elements associated with trusted SRH care such as showing compassion, respecting and non-judging, taking time, providing information, and assuring agency. Participants also voiced a desire for holistic care that addressed the lived experiences of the individual. Participants took quality of care into account when care-seeking but sometimes had to weigh out preferences for quality with issues of affordability.
    CONCLUSIONS: Access to quality person-centered care is an essential component of realized access to SRH services. Measures of equitable access and quality should account for experiences of quality care that include both provider and staff interactions as well as the larger healthcare environment and ability to use quality care despite financial constraints.
    CONCLUSIONS: Quality family planning care should involve both clinicians and staff to incorporate showing compassion, providing respectful and non-judgmental care, taking time with patients, providing information, assuring agency in decision-making, as well as addressing the lived experiences of individuals.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:整个美国的药物诱导死亡率持续上升。迄今为止,评估患者对药物使用障碍(SUD)治疗的偏好和优先事项的措施有限,许多患者无法获得循证治疗方案。寻求SUD治疗的患者及其家人可以开始在线搜索SUD治疗设施,在那里他们可以找到关于个别设施的信息,以及通过Google或Yelp等流行平台对患者生成的基于网络的评论的摘要。对卫生保健设施的基于网络的审查可以反映有关与积极或消极的患者满意度相关的因素的信息。患者对SUD治疗的满意度与药物引起的死亡率之间的关系尚不清楚。
    目的:本研究的目的是检查SUD治疗设施的在线综述内容与药物诱导的状态死亡率之间的关系。
    方法:对2005年9月至2021年10月期间列出的药物滥用和精神卫生服务管理局(SAMHSA)指定的SUD治疗设施的在线评论和评级进行了横断面分析。主要结果是(1)SUD治疗设施的平均在线评级从1星(最差)到5星(最佳),以及(2)疾病控制和预防中心(CDC)WONDER数据库(2006-2019)的平均药物诱导死亡率。确定了评论中频率不同的单词簇。使用3级线性模型来估计在线评论评级与药物引起的死亡率之间的关联。
    结果:本研究共纳入589家SAMHSA指定的设施(n=9597条综述)。将药物诱导的死亡率与平均值进行比较。大约一半(24/47,51%)的州死亡率低于平均水平(“低”)(平均每100,000人死亡13.40,SD2.45),一半(23/47,49%)的药物诱导死亡率高于平均水平(“高”)(平均21.92,SD3.69每100,000人死亡)。与低药物死亡率相关的前5个主题包括戒毒和成瘾康复服务(r=0.26),对康复的感激(r=-0.25),感谢治疗(r=-0.32),关怀的员工和惊人的经验(r=-0.23),和个性化恢复计划(r=-0.20)。与高死亡率相关的前5个主题是医生或提供者的护理(r=0.24),粗鲁和不敏感的护理(r=0.23),药物和处方(r=0.22),前台和接待经验(r=0.22),和对沟通的不满(r=0.21)。在多级线性模型中,每100,000人中有10人死亡的州死亡率增加与平均Yelp评分低0.30相关(P=.005)。
    结论:在州一级,SUD治疗设施的较低在线评级与较高的药物诱导死亡率相关。患者体验要素可能与州级死亡率相关。从网上确定的主题,有机地得出的患者内容可以为改善高质量和以患者为中心的SUD护理提供信息。
    BACKGROUND: Drug-induced mortality across the United States has continued to rise. To date, there are limited measures to evaluate patient preferences and priorities regarding substance use disorder (SUD) treatment, and many patients do not have access to evidence-based treatment options. Patients and their families seeking SUD treatment may begin their search for an SUD treatment facility online, where they can find information about individual facilities, as well as a summary of patient-generated web-based reviews via popular platforms such as Google or Yelp. Web-based reviews of health care facilities may reflect information about factors associated with positive or negative patient satisfaction. The association between patient satisfaction with SUD treatment and drug-induced mortality is not well understood.
    OBJECTIVE: The objective of this study was to examine the association between online review content of SUD treatment facilities and drug-induced state mortality.
    METHODS: A cross-sectional analysis of online reviews and ratings of Substance Abuse and Mental Health Services Administration (SAMHSA)-designated SUD treatment facilities listed between September 2005 and October 2021 was conducted. The primary outcomes were (1) mean online rating of SUD treatment facilities from 1 star (worst) to 5 stars (best) and (2) average drug-induced mortality rates from the Centers for Disease Control and Prevention (CDC) WONDER Database (2006-2019). Clusters of words with differential frequencies within reviews were identified. A 3-level linear model was used to estimate the association between online review ratings and drug-induced mortality.
    RESULTS: A total of 589 SAMHSA-designated facilities (n=9597 reviews) were included in this study. Drug-induced mortality was compared with the average. Approximately half (24/47, 51%) of states had below average (\"low\") mortality rates (mean 13.40, SD 2.45 deaths per 100,000 people), and half (23/47, 49%) had above average (\"high\") drug-induced mortality rates (mean 21.92, SD 3.69 deaths per 100,000 people). The top 5 themes associated with low drug-induced mortality included detoxification and addiction rehabilitation services (r=0.26), gratitude for recovery (r=-0.25), thankful for treatment (r=-0.32), caring staff and amazing experience (r=-0.23), and individualized recovery programs (r=-0.20). The top 5 themes associated with high mortality were care from doctors or providers (r=0.24), rude and insensitive care (r=0.23), medication and prescriptions (r=0.22), front desk and reception experience (r=0.22), and dissatisfaction with communication (r=0.21). In the multilevel linear model, a state with a 10 deaths per 100,000 people increase in mortality was associated with a 0.30 lower average Yelp rating (P=.005).
    CONCLUSIONS: Lower online ratings of SUD treatment facilities were associated with higher drug-induced mortality at the state level. Elements of patient experience may be associated with state-level mortality. Identified themes from online, organically derived patient content can inform efforts to improve high-quality and patient-centered SUD care.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:以患者为中心的临床试验似乎更成功(例如,临床结果,改善沟通,相互授权,态度改变),因此,行动研究可能是一个重要的领域。本研究探讨了社区学术伙伴关系(CAP)的活动阶段的形成和执行。
    方法:成员由行业利益相关者组成,医疗保健/学术机构,以及有癌症幸存者和/或护理人员生活经验的患者/家庭。回顾过去,CAP成员描述了伙伴关系发展中存在的促进和/或阻碍因素。使用了文件审查程序。三次联合呼吁程序会议的实地说明,专注于了解临床试验的参与,使用主题方法进行了分析。
    结果:存在七个促进因素和三个阻碍因素。人际关系(vs.操作)过程更经常被称为有影响的促进因素。出现的主题包括“作为治疗选择的试验”,\'留下遗产\',和\'时机至关重要。
    结论:这项研究提供了以患者为中心的观点,探讨了参与临床试验的障碍/挑战以及如何改善未来的看法。
    当患者参与时,临床试验更成功,他们的观点在研究设计中得到了考虑。社区-学术伙伴关系(CAPs)是通过建立合作,使所有相关方发挥公平作用,从而确保患者更多地参与研究过程的一种方法。我们提供了一个与行业利益相关者合作的例子,医疗保健/学术机构,和患者以及有癌症幸存者和/或护理人员生活经验的家庭。这里描述了CAP的两个阶段:活动的形成和执行阶段。形成阶段涵盖了CAP的协作过程和开发。在我们的研究中,为了更好地理解这个阶段,CAP成员描述了在伙伴关系发展过程中进展顺利和不顺利的情况。我们发现更多的方面进展顺利,并且与CAP成员之间的关系和沟通质量相关的过程很重要。活动执行阶段侧重于CAP如何努力实现商定的结果。在我们的研究中,为了更好地理解这个阶段,我们回顾了以往CAP会议的记录,重点是探讨参与临床试验作为治疗选择.我们发现,当涉及到参与临床试验时,有癌症生活经历的患者和/或护理人员,认为这种治疗选择的时机很重要,参与的原因包括想要留下遗产。在本文中,我们描述了参与临床试验的一些挑战,由患者和护理人员识别,并讨论如何提高未来临床试验参与的观点。
    BACKGROUND: Clinical trials that are patient-centered appear to be more successful (e.g., clinical outcomes, improved communication, mutual empowerment, changed attitudes), thus, action research may be a field of importance. The current study explores the Formation and Execution of Activities phases of a community-academic partnership (CAP).
    METHODS: Members consisted of industry stakeholders, a healthcare/academic institution, and patients/families with lived experiences as cancer survivors and/or caregivers. Retrospectively, CAP members described the facilitating and/or hindering factors present in the partnership development. A document review process was used. Field notes from three CAP meetings, which focused on understanding clinical trial participation, were analyzed using a thematic approach.
    RESULTS: Seven facilitating and three hindering factors were present. Interpersonal (vs. operational) processes were referenced as influential facilitating factors more often. Themes that emerged included \'trials as a treatment option\', \'leaving a legacy\', and \'timing is critical.\'
    CONCLUSIONS: This study provides a patient-centered perspective on barriers/challenges of clinical trial participation and how to improve future perceptions.
    Clinical trials are more successful when patients are engaged, and their perspectives have been considered in the study design. Community-academic partnerships (CAPs) are one way to ensure patients are more engaged in the research process by creating a collaboration where all parties involved play an equitable role. We provide an example of a CAP with an industry stakeholder, a healthcare/academic institution, and patients as well as families with lived experiences as cancer survivors and/or caregivers. Described here two phases of the CAP: the Formation and the Execution of Activities phases. The Formation phase covers the collaboration process and development of the CAP. In our study, to better understand this phase, CAP members described what did and did not go well during the partnership development. We found more aspects went well than did not and that processes related to the quality of the relationship and communication among CAP members were important. The Execution of Activities phase focuses on how the CAP is working towards an agreed upon outcome. In our study, to better understand this phase, we reviewed notes taken at previous CAP meetings that focused on exploring participation in clinical trials as a treatment option. We found that when it comes to participation in clinical trials, patients and/or caregivers with lived experiences with cancer, felt that timing of this treatment option was important and that reasons for participation included wanting to leave a legacy. In this paper we describe some challenges of clinical trial participation, identified by patients and caregivers, and discuss how to improve views of clinical trial participation in the future.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号